Evidence map›Paper›PMID 31643038›Full record

ReviewReviews in endocrine & metabolic disorders2019

Calcium citrate: from biochemistry and physiology to clinical applications.

Andrea Palermo, Anda Mihaela Naciu, Gaia Tabacco, Silvia Manfrini, Pierpaolo Trimboli, Fabio Vescini, Alberto Falchetti

Abstract readReview
PubMed Publisher
In one paragraph

Review in Reviews in endocrine & metabolic disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 53 citations in OpenAlex.

  1. Calcium Citrate Versus Calcium Carbonate in the Management of Chronic Hypoparathyroidism: A Randomized, Double-Blind, Crossover Clinical Trial.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Trial
  2. Article
  3. Review
  4. Article
  5. Supplements for bone health.Archives of endocrinology and metabolism · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Unlocking New Approaches to Urolithiasis ManagementCurrent pharmaceutical biotechnology · 2024
    Review
  12. Osteomalacia Is Not a Single Disease.International journal of molecular sciences · 2022
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Andrea PalermoUnit of Endocrinology and Diabetes, Campus Bio-Medico University, Rome, Italy. a.palermo@unicampus.it.ORCID 0000-0002-1143-4926
Anda Mihaela NaciuUnit of Endocrinology and Diabetes, Campus Bio-Medico University, Rome, Italy.
Gaia TabaccoUnit of Endocrinology and Diabetes, Campus Bio-Medico University, Rome, Italy.
Silvia ManfriniUnit of Endocrinology and Diabetes, Campus Bio-Medico University, Rome, Italy.
Pierpaolo TrimboliDepartment of Nuclear Medicine and Thyroid Centre, Imaging Institute of Southern Switzerland, Lugano, Switzerland.
Fabio VesciniEndocrinology and Metabolism Unit, University-Hospital S. Maria della Misericordia of Udine, 33100, Udine, Italy.
Alberto FalchettiIstituto Auxologico Italiano, IRCCS, Unit for Bone Metabolism Diseases and Diabetes & Lab of Endocrine and Metabolic Research, University of Milan, Milan, Italy.
Università Campus Bio-Medico · ITLaboratory for Biomedical Neurosciences · CHOspedale Santa Maria della Misericordia di Udine · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adequate daily calcium intake should normally be achieved by dietary sources. Since low calcium diets are quite common in subjects that do not reach the recommended intake and particularly those at risk of fractures, calcium supplements may become necessary. Different forms of calcium salts are available, but products containing calcium citrate and calcium carbonate complexes are the most frequently used. Although only limited evidence on the efficacy and long-term safety of calcium citrate is available, these supplements may represent a valuable product for the management of different chronic pathological conditions. The aim of this review was to evaluate the current and potential clinical applications of calcium citrate. In particular, we focused on the use of calcium citrate supplementation in subjects with osteoporosis or in bariatric patients. Other pathological conditions that could benefit calcium citrate supplementation may include achloridria, chronic hypoparathyroidism and hypocitraturic subjects with moderate/high risk of nephrolithiasis. Indeed, citrate salts are widely used in the treatment of nephrolithiasis, since they have shown an inhibitory effect on kidney stone formation and recurrence.

Indexed as

AnimalsBariatric SurgeryCalcium CitrateFractures, BoneHumansNephrolithiasisOsteoporosisCalcium CitrateBariatric surgeryCalciumCitrateFractureOsteoporosis

Identifiers

PMID31643038
OpenAlexW2981815855

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.